A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats-Reference-Cited by-同舟云学术

A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats

Published:2019-02 Issue: Volume:154 Page:38-50
ISSN:1046-2023
Container-title:Methods
language:en
Short-container-title:Methods

Author:

Moore Gregory L.,Bernett Matthew J.,Rashid Rumana,Pong Erik W.,Nguyen Duc-Hanh T.,Jacinto Jonathan,Eivazi Araz,Nisthal Alex,Diaz Juan E.,Chu Seung Y.,Muchhal Umesh S.,Desjarlais John R.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Molecular Biology

Reference65 articles.

1. Next generation antibody drugs: pursuit of the ‘high-hanging fruit';Carter;Nat. Rev. Drug Discov.,2018

2. The making of bispecific antibodies;Brinkmann;MAbs,2017

3. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model;Kitazawa;Nat. Med.,2012

4. Tumor regression in cancer patients by very low doses of a T cell-engaging antibody;Bargou;Science,2008

5. http://tabs.craic.com/. (Accessed 7/20/2018).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developability considerations for bispecific and multispecific antibodies;mAbs;2024-08-27

2. Human gut microbes express functionally distinct endoglycosidases to metabolize the same N-glycan substrate;Nature Communications;2024-06-15

3. Development of a 10 g/L process for a difficult-to-express multispecific antibody format using a holistic process development approach;Journal of Biotechnology;2024-06

4. A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications;Antibody Therapeutics;2024-05-29

5. IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion;Molecular Cancer Therapeutics;2024-05-10